The goal of this NIIMBL project is to align this powerful technology with the most urgent needs of biopharma. This will include evaluating assay performance with Tier 1 partner samples. In addition, based on input from working groups with Tier 1 partners, we will determine the optimal software tools required for analysis of the resulting cIEF and...

NIIMBL: Education and Training Resources

Automated bioprocess test beds will be designed and implemented across three sites. Each test bed will consist of process Sensors and software for Process control, Integration, Data analysis, process Evolution, and Reporting. The test beds in the SPIDER Network will be used for training that addresses automation topics relevant to engineering...

Researchers in Carnegie Mellon University's Department of Chemical Engineering are collaborating with leading biotechnology company Genentech, a member of the Roche Group, and LumaCyte, a biotechnology instrumentation company based in Charlottesville, Virginia, to develop an advanced biomanufacturing technology for adventitious agent testing, or...

NIIMBL, a Manufacturing USA institute, continues to build momentum toward new, innovative biomanufacturing technologies.

That momentum was on display at the National Meeting as Dr. Dhinakar Kompala of Sudhin Biopharma Co., an early member, showed off the company’s new single-use compact settler for clarifying cell culture broth. The settler is...